Email Updates

You are here

Webinar & Meeting Reports

  • June 4, 2015

    Rapid advances in molecular genetics and bio-informatics allow more and better data on the phylogeny of HIV to be collected. The genetic diversity among HIV strains within individual patients, communities and globally allows the dynamics of transmission and evolution of the virus to be studied in ever greater detail. The implications for drug resistance, vaccine development, transmission networks and evaluation of prevention interventions are beginning to be understood. The challenge is to translate the new science into more effective ways to prioritize the HIV response and to monitor the impact of different intervention approaches. This meeting brought together scientists, policy makers, and international organizations dedicated to advancing our scientific knowledge of HIV and translating that information into the most effective programs for reducing transmission of the virus.

  • June 3, 2015
    A variety of safe and effective female condoms currently exist. However, regulatory hurdles limit new products from entering consumer markets. With the pipeline of new receptive-partner initiated condoms growing, advocates must understand how regulatory issues determine product introduction and approval in their country.
  • May 28, 2015

    A special presentation and discussion of new research on the relationship between hormonal contraception and HIV was hosted by CHANGE (Center for Health and Gender Equity). This interactive webinar brought together researchers, policy experts and advocates to discuss applications for this research in ensuring that all women and girls have access to the most effective family planning, reproductive health and HIV prevention information and services. Webinar slides are available.

  • May 27, 2015
    The goal of the PrEP Summit: A Skills Building Conference for Frontline Workers was to increase PrEP and PEP awareness and knowledge among frontline HIV prevention workers who serve high-risk populations such as MSM (including young MSM), transgender women, Black and Latino men and women in New York City. PrEP and PEP, in combination with interactive client-centered counseling, can be highly effective tools for HIV prevention. Attendees of the summit increased their understanding of PrEP and PEP use and current research and learned to implement methods to integrate PrEP and PEP information into existing HIV testing and outreach programs.
  • May 20, 2015

    One of the major barriers to finding a cure for HIV is the ability to count how much latent virus persists inside the cells of a person living with HIV who is on effective treatment. Drs. Janet and Robert Siliciano shared the current challenges & strategies to measuring the latent HIV reservoir.

  • May 18, 2015
    Vaccine-O-Licious is an annual event designed to spread the word about HIV Vaccine Awareness Day. The event brought together a variety of performers uniting through dance and song. Peppermint hosted this exciting evening of entertainment, with a little education too!
  • May 18, 2015

    GHTC and COHRED discussed in a webinar approaches to achieving access to new products, and how those approaches can impact the R&D process. The discussion included multiple perspectives on the topic and a Q&A with the panelists.

  • May 18, 2015

    On May 18, advocates around the world observed HIV Vaccine Awareness Day (HVAD)—an annual commemoration of the need for and commitment to the ongoing search for a vaccine. AVAC convened a webinar—Vaccines in Vivo: Advances in AIDS Vaccine Research—and updated a number of materials, including our “HVAD Toolkit” for those interested in easy-to-digest research updates.

  • May 18, 2015

    On May 18 every year, HIV prevention advocates around the world raise their voices about the urgent need to continue the search for a safe and effective AIDS vaccine, and especially to recognize the enormous contribution of the thousands of volunteers who have participated in vaccine trials, without which this research would not be possible. Here is a partial list of events that happened all around the world.

  • April 28, 2015
    IRMA and AVAC hosted this webinar on rectal agents in development, including the antiretroviral drug Dapivirine and Griffithsin, a potent, anti-HIV protein derived from red algae. We also learned about exciting plans for developing new microbicide formulations like rectal douches.

Pages